domingo, 22 de enero de 2012

The National Institutes of Health Undiagnosed Dise... [Genet Med. 2012] - PubMed - NCBI

Genet Med. 2012 Jan;14(1):51-9. doi: 10.1038/gim.0b013e318232a005. Epub 2011 Sep 26.

The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases.

Source

1] NIH Undiagnosed Diseases Program, NIH, Bethesda, Maryland, USA [2] Office of the Clinical Director, National Human Genome Research Institute, NIH, Bethesda, Maryland, USA [3] Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, Maryland, USA.

Abstract

Purpose:This report describes the National Institutes of Health Undiagnosed Diseases Program, details the Program's application of genomic technology to establish diagnoses, and details the Program's success rate during its first 2 years.Methods:Each accepted study participant was extensively phenotyped. A subset of participants and selected family members (29 patients and 78 unaffected family members) was subjected to an integrated set of genomic analyses including high-density single-nucleotide polymorphism arrays and whole exome or genome analysis.Results:Of 1,191 medical records reviewed, 326 patients were accepted and 160 were admitted directly to the National Institutes of Health Clinical Center on the Undiagnosed Diseases Program service. Of those, 47% were children, 55% were females, and 53% had neurologic disorders. Diagnoses were reached on 39 participants (24%) on clinical, biochemical, pathologic, or molecular grounds; 21 diagnoses involved rare or ultra-rare diseases. Three disorders were diagnosed based on single-nucleotide polymorphism array analysis and three others using whole exome sequencing and filtering of variants. Two new disorders were discovered. Analysis of the single-nucleotide polymorphism array study cohort revealed that large stretches of homozygosity were more common in affected participants relative to controls.Conclusion:The National Institutes of Health Undiagnosed Diseases Program addresses an unmet need, i.e., the diagnosis of patients with complex, multisystem disorders. It may serve as a model for the clinical application of emerging genomic technologies and is providing insights into the characteristics of diseases that remain undiagnosed after extensive clinical workup.Genet Med 2012:14(1):51-59.

PMID:
22237431
[PubMed - in process]
The National Institutes of Health Undiagnosed Dise... [Genet Med. 2012] - PubMed - NCBI

No hay comentarios:

Publicar un comentario